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Bioactive silicate glass scaffolds were fabricated by a robocasting process in which all the movements of the printing head were
programmed by compiling a script (text file). A printable ink made of glass powder and Pluronic F-127, acting as a binder, was
extruded to obtain macroporous scaffolds with a grid-like three-dimensional structure. )e scaffold architecture was investigated
by scanning electron microscopy and microtomographic analysis, which allowed quantifying the microstructural parameters
(pore size 150–180 μm and strut diameter 300 μm). In vitro tests in simulated body fluid (SBF) confirmed the apatite-forming
ability (i.e., bioactivity) of the scaffolds. )e compressive strength (around 10MPa for as-produced scaffolds) progressively
decreased during immersion in SBF (3.3MPa after 4 weeks) but remains acceptable for bone repair applications. Taken together,
these results (adequate porosity and mechanical strength as well as bioactivity) support the potential suitability of the prepared
scaffolds for bone substitution.
1. Introduction
Bone substitution in critical- and medium-sized defects,
resulting from injuries, degenerative pathologies, and tumor
removal, is still considered one of the major clinical chal-
lenges of our time. Hence, there has been a considerable
increase in the demand for bone grafts over the last years [1].
Autologous bone is still considered the “gold standard” in
realizing bone grafting procedures mainly due to its ex-
cellent biocompatibility, but the need to overcome the limits
related to tissue availability and donor site morbidity is
driving researchers towards other options. Allografts and
xenografts are available in a virtually unlimited amount but
can carry the risk of disease transmission, are often resorbed
more quickly as compared to the host bone healing rate, and
may be refused by the patient due to ethical or religious
concerns [2]. Hence, many efforts have been carried out in
the last two decades for the development of engineered
tissues created by bioreactors [3] as well as synthetic bone
grafts exhibiting osteoconductive, osteoinductive, and
osteogenetic properties [4–6].
Up to now, among all the available synthetic materials
used in the production of bone grafts (i.e., polymers, ce-
ramics, and composites [7]), undoubtedly bioactive glasses
(BGs) show highly attractive properties as basic materials for
the fabrication of three-dimensional (3D) scaffolds based on
bone tissue engineering (BTE) strategies [8, 9]. )e suit-
ability of BGs relies on their unique capability to both create
a stable material-device interface by inducing the formation
of a hydroxyapatite (HA) layer on their surface and promote
the expression of osteogenetic factors by osteoprogenitor
cells [10, 11].
When designing scaffolds for BTE, interconnected pores
with mean diameter ≥100 µm and open porosity ≥50 vol.%
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are considered to be the minimum requirements to have a
proper tissue ingrowth and cell migration within the grafting
material [12–14]. Moreover, achieving a suitable mechanical
response of the device is essential in order to guarantee both
structural integrity and adequate support over the whole
duration of the healing process [15]. Unfortunately, almost
all the traditional manufacturing processes, deeply reviewed
elsewhere [16–18], do not allow achieving an accurate
control on such parameters.
As safety and reliability of the implant-manufacturing
process represent moral imperatives in health sciences,
methods for the production of complex geometries and
patient-specific devices are strongly required. As a result,
starting from the early ’80s, solid freeform fabrication (SFF)
techniques, also known as additive manufacturing (AM)
technologies, gained increasing scientific interest because of
the possibility to easily tailor the device properties by simply
acting on process parameters [19, 20]. Such technologies, in
fact, are based on bottom-up approaches, where the object is
produced layer by layer starting from a computer-aided
design (CAD) file (.stl file) or text scripts [15]. All these
aspects are of particular interest in BTE where obtaining
customized devices is a primary goal [21]. A high control on
porosity, pore size, and interpore interconnectivity can
actually be achieved by relatively simple SFF processes.
)ese techniques show also promise for large-scale
manufacturing, where high reproducibility of the devices
is required.
Moreover, having a high control on the scaffold archi-
tecture makes it possible to tailor the mechanical response of
the device during the design phase [22]. In this regard, it
should be pointed out that both compressive strength and
elastic modulus of the bone should ideally be matched by the
scaffold. )ese parameters depend on both the extruded
material properties and the scaffold pore/strut structure.
Several SFF techniques have already been used for BTE
scaffold fabrication, including 3D printing (3DP), fused
deposition modeling (FDM), ink-jet printing, stereo-
lithography (SL), and selective laser sintering (SLS) [20].
However, very little information is available in the literature
regarding the processing of bioactive glasses by SFF tech-
niques. Probably, robocasting is the most common and
powerful direct ink-writing technique for the processing of
glass and glass-ceramic scaffolds. )is technique is based on
the continuous extrusion of a filament (ink) from a robot-
controlled nozzle onto a building platform [22]. )e ink is a
slurry, composed of glass or ceramic particles and a poly-
meric binder to form a colloidal suspension, characterized
by well-defined rheological properties [23]. Usually, the
process does not require the use of a high concentration of
binder, allowing sintered parts to be obtained in a short time
[22]. Pluronic F-127 is one of the three most commonly used
binders for robocasting in bone applications [24–26], to-
gether with ethyl cellulose/polyethylene glycol and car-
boxymethyl cellulose [27–30].
Robocast bioceramic scaffolds were produced for the
first time in 2010 by Franco et al., who developed a hydrogel-
based ink containing calcium phosphates (HA and β-TCP)
[24]. Since then, both commercial 45S5 Bioglass® and 13-93
glass were processed by robocasting by several research
groups. In 2013, Liu et al. used robotic deposition to produce
13-93 glass-based grid-like microstructured scaffolds with
47 vol.% porosity and 300 µm pore width. Flexural and
compressive mechanical tests were performed before and
after both bioactivity tests in simulated body fluid (SBF) and
in vivo tests in a rat subcutaneous model. It was found that
compressive strength decreased both after 2-week immer-
sion in SBF and in vivo implantation. Moreover, a shift from
brittle to elastoplastic response was observed after 2- and 4-
week implantation in vivo, thus demonstrating the bone-like
behaviour of such devices and their suitability in load-
bearing applications [26].
In 2014, fully vitreous 45S5 Bioglass®-based scaffoldswith interconnected porosity ranging from 60 to 80 vol.%
were successfully produced for the first time. All the scaffolds
showed compressive strength comparable to that of the
trabecular bone (2–13MPa), even when sintered below the
crystallization temperature [27].
More recently, 45S5 Bioglass®-based scaffolds reinforcedby HA/PCL nanocomposite coatings were obtained by
Motealleh et al. [30], who interestingly investigated the
effects of different postprocessing thermal treatments on the
scaffold mechanical response. )e CAD-derived original
architecture was successfully retained upon sintering both in
amorphous and highly crystallized scaffolds, with com-
pressive strengths of 2MPa and 11MPa, respectively, which
are definitely in the range of the trabecular bone.
In a recent study, functionally graded porous devices
were successfully obtained by Mattioli-Belmonte et al. [31]
who used a robocasting system, called the pressure-assisted
microsyringe (PAM), to produce bioactive glass/poly(lactic-
co-glycolic acid) (PLGA) 2D porous structures characterized
by a well-defined topology. )e layers were then assembled
in order to obtain a 3D bone-like scaffold [31]. It was
demonstrated that the elastic modulus was comparable to
that of the cancellous bone, and osteoblastic differentiation
of human periosteal precursor cells was observed, showing
great promise for bone tissue engineering applications.
In the present work, highly bioactive and fully amor-
phous grid-like scaffolds for bone regeneration were pro-
duced by robocasting using a six-oxide silicate glass as the
basic material for the ink formulation. )e aim was to
demonstrate that it is possible to obtain 3D structures with
suitable porosity with a rather simple method, avoiding the
use of ultrafine powders, thin nozzles, and complex ink
preparation.
2. Materials and Methods
2.1. Glass Preparation. )e basic material used to manu-
facture the scaffolds was a silicate glass (composition
47.5SiO2-10Na2O-10K2O-10MgO-20CaO-2.5P2O5 mol.%)
originally developed by Verne´ et al. [32] at Politecnico di
Torino. )is glass, referred to as 47.5B, was produced by a
standard melting method in a platinum crucible. )e raw
precursors (SiO2, Na2CO3, K2CO3, (MgCO3)4·Mg(OH)2·
5H2O, CaCO3, and Ca3(PO4)2 high-purity powders pur-
chased from Sigma-Aldrich) were homogeneously mixed in
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the crucible and melted in air at 1500°C for 30min. )e melt
was then quenched in deionized water to produce a frit that
was ball-milled (Pulverisette 0, Fritsch, Germany) and sieved
to obtain a final particle below 32 μm by using a stainless
steel sieve (Giuliani Technologie Srl; mesh 32 μm).
2.2. Scaffold Fabrication by Robocasting. )e 47.5B glass was
thought to be very suitable to produce completely amor-
phous—and hence highly bioactive—porous scaffolds due to
its large hot-working range (difference between onset of
crystallization (Tx) and glass transition temperature (Tg),
Tx−Tg � 260°C), as determined in a previous study [32].
Pluronic F-127 (Sigma-Aldrich) was used as a binder for
the preparation of the glass-based ink. )e ink formulation
was optimized through some preliminary trials and involved
the addition of 35 vol.% of glass to an optically clear water-
based solution containing 27.5 wt.% of Pluronic F-127. Prior
to adding the glass, the Pluronic F-127 solution was stirred
overnight while being maintained at low temperature in an
ice bath due to the thermosensitive behaviour of the binder.
)e glass-containing ink was thenmixed for 1min by using a
vortex mixer (Ika-Werk shaker, type Vibrofix VF1 elec-
tronic) at 2500 rpm and cooled for 1min in the ice bath. Five
mixing-cooling cycles were performed to allow achieving
good dispersion of the glass particles.
)e plastic cartridge connected to the robocasting ma-
chine (3Dn-Tabletop, nScrypt Inc., Orlando, FL, USA) was
filled with the ink, which was left to stabilize for 1 h before
printing. )e only movement that was allowed to the
printing tower was along the (vertical) z-axis, and its po-
sition determined the printing height. Plastic tips with an
inner diameter of 410 μm (Nordson EFD Optimum®SmoothFlow™) were used to extrude the ink. )e plate
under the nozzle was moved on the x-y plane with respect to
the printing tower so that the ink was extruded according to
the correct pattern. )e printing accuracy was 10 μm along
the x- and y-axes and about 5 μm along the z-axis [33].
Acetate sheets (Colour Copier and Laser Transparency
OHP Film, Folex AG, Seewen, Switzerland) were used as the
printing substrate due to their flatness, good adhesions they
have with the ink, and easiness to detach the scaffolds from
them once they are dry [34].
Once the cartridge was loaded and fitted in position and
the acetate sheet was placed on the platform, the processing
parameters were adjusted using the software (MachineTools
3.0) provided by nScrypt. )e desired structure was obtained
by programming every single movement that the print head
must do along the x-, y-, and z-axes through compiling a
design script, written as a text file. )e printing speed was
2mm/s, and the pressure used to extrude the ink was in the
range of 1.24–1.51 bar; the raster pattern is shown in Figure 1.
Robocast 47.5B scaffolds were porous cuboids
(length�width� 7.5mm) with a grid-like structure and
were made of 20 glass layers (height about 4.5mm). Once the
printing was completed, the scaffolds were left to dry for 48 h
in air and finally detached from the acetate sheet. A mul-
tistep thermal treatment (three stages at 200, 400, and 500°C
for 30min each followed by a final stage at 600°C for 1 h;
heating rate 1°C/min) was eventually performed to allow the
removal of the organic binder and the sintering of glass
particles. Only the last heat treatment, being performed at a
temperature higher than Tg, led to glass sintering, while the
others were part of the burning-out process of the binder,
which was carried out slowly to ensure the complete removal
of any organic residue and avoid cracking phenomena due to
sudden shrinkage.
2.3. Characterizations
2.3.1. X-Ray Diffraction. Both as-quenched glass and sintered
scaffolds (after being crushed into powder) underwent wide-
angle X-ray diffraction (XRD; 2θ within 20–70°) to detect the
presence of crystalline phases. A X’Pert Pro PW3040/60 dif-
fractometer (PANalytical, Eindhoven, Netherlands) was used;
the experimental setup included operating voltage 40 kV,
filament current 30mA, Bragg-Brentano camera geometry
with Cu Kα incident radiation (wavelength λ� 0.15405nm),
step size 0.02°, and fixed counting time per step 1 s.
2.3.2. In Vitro Bioactivity. )e bioactivity of the robocast
scaffolds, in terms of HA formation and ionic release in
vitro, was carried out by properly adapting the testing
procedure proposed by Macon et al. [35]. )e experiments
involved the immersion of triplicate samples in Kokubo’s
SBF [36] for 6, 24, 48, 72, 168, and 336 h. )e ratio between
sample mass and SBF volume at the beginning of the ex-
periments was fixed at 1.5mg/ml. )e specimens were
placed into an orbital shaker incubator (Multitron AJ 118 g,
Infors, Bottmingen, Switzerland) at 37°C under a constant
speed of 100 rpm. )e solution was analyzed at each time
point by means of inductively coupled plasma optical
emission spectroscopy (ICP-OES) (5110 ICP-OES, Agilent
Technologies) in order to evaluate the concentration of ions
in the solution. After being extracted from the solution, the
samples were gently rinsed with distilled water and left to dry
overnight at room temperature. )e results were expressed
as mean± standard deviation.
9.54mm
0.636mm
Figure 1: Raster pattern used to print the scaffolds.
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2.3.3. Morphology and Porosity. )e scaffolds were in-
vestigated before and after in vitro tests by a field-emission
scanning electron microscope (FE-SEM; Supra™ 40, Zeiss,
Oberkochen, Germany) equipped with an energy dispersive
spectroscopy (EDS) detector in order to evaluate the pore-
strut morphology and the formation of new phases on the
surface of SBF-treated samples. )e specimens were sputter-
coated with chromium prior to the analysis and inspected at
an accelerating voltage of 15 kV.
)e total porosity of the scaffolds was assessed by mass-
volume measurements as (1− ρ/ρ0) × 100, where ρ is the
apparent density of the scaffold and ρ0 is the bulk density.
)e porosity was expressed as mean± standard deviation
calculated on five specimens.
For micro-CTanalysis, the samples were X-ray scanned in
the dry state in a Phoenix Nanotom S machine (General
Electric Measurement and Control), at a source voltage of
110 kV and a source current of 110 µA. No X-ray filters were
used.)e scanning modalities for the robocast 47.5B scaffolds
before and after immersion in SBF are reported in Table 1. A
translational motion compensation was performed in order to
guarantee a perfect matching of the 0° and 360° shadow
images. )ereafter, the projection images were used to re-
construct the investigated scaffolds by means of the Radon
transform [37, 38] as algorithmized in the software datos|x
reconstruction provided by the manufacturer. VGStudio Max
2.0 from Volume Graphics was employed for visual evalua-
tion and detail measurements on strut and void sizes as well as
for calculations of porosity. An automated calibration routine
integrated into VGStudio Max 2.0 was used to define material
boundaries. )e software determines the background peak
and the material peak in the grey value histogram and cal-
culates the grey value of the material boundary. VGStudio
Max 2.0 was also used to export image stacks in the DICOM
format. )is format can be read into the BoneJ plugin [39]
running under the ImageJ software package (version 1.51t)
[40]. BoneJ (version 1.4.2) was used to extract information
following an approach used for the trabecular bone where
bone volume, total volume, trabecular thickness, and tra-
becular spacing (i.e., pore size) are determined [41].
2.3.4. Mechanical Characterization. )e compressive
strength of the scaffolds before and after in vitro tests (2 and
4weeks in SBF) was evaluated through crushing tests by
using an MTS machine (Model 43, MTS, Minnesota, USA;
cell load 5 kN and cross-head speed 1mm·min−1). )e
failure stress was calculated as the ratio between the max-
imum load registered during the test and the resistant cross-
sectional area measured by callipers. )e compressive
strength was expressed as mean± standard deviation cal-
culated on five specimens for each type.
3. Results and Discussion
3.1.MicrostructureandMorphology. Figure 2 shows the XRD
spectra of both the as-quenched material and the sintered
scaffolds. As expected, no diffraction peaks can be detected,
but only a broad amorphous halo in the range of 20 to 35° is
visible, which is typical of silicate glasses (red pattern). No
microstructural changes in the material were revealed after
the thermal treatment at 600°C, which demonstrates that
47.5B scaffolds remain in an amorphous state (black pattern).
)is is beneficial for the bioactivity, as suggested by some
studies reporting that devitrification can reduce the apatite-
forming ability of bioactive glass-derived materials [42].
)e scaffold structure obtained by robocasting is highly
regular with a grid-like arrangement of the pores
(Figure 3(a)). )e struts (rods) remained straight during the
sintering process and exhibited a quite regular circular
section.)e porosity is made of regular macrochannels, both
vertical and horizontal, generated by the separation between
glass lines and the tilting of each newly juxtaposed layer with
respect to the underlying one.
More accurate morphological investigations were car-
ried out by SEM, especially in order to understand the level
of sintering reached during the thermal treatment. )e
scaffolds exhibit well-densified struts (rods) in which the
glass particles are no more distinguishable (Figure 3(b)).
High-magnification analysis reveals that the interparticle
porosity almost completely disappeared as a result of sin-
tering and the glass particles are fused together, also in the
areas of contact between adjacent rods (Figure 3(c)). Few
small spherical pores derived from air bubbles entrapped in
the ink can also be observed. )e cross-sectional size of the
channels (100–200 μm) is potentially suitable to support new
bone formation. In fact, pores above 100 μm allow osteo-
blastic cell colonization and proper vascularization, thus
avoiding hypoxic growth conditions of the bone [9].
)e total porosity of the scaffolds was 42.5± 4.5 vol.%,
which is close to the minimum threshold of acceptability
recommended for bone tissue engineering applications
(about 50 vol% [43]). Further optimizations of the robo-
casting process could allow increasing the porosity without
negatively affecting the structural integrity. )e low value of
standard deviation demonstrates the good reproducibility of
the fabrication process.
Micro-CT reconstructions of two-dimensional sections
of the scaffolds are reported in Figure 4.
)e tomographic images showed good regularity of the
pore-strut structure and rod diameter: the voids that are
visible in the filaments are due to air bubbles that remained
entrapped inside the ink. In some cases, these voids origi-
nated from full-thickness cracks in the filaments as a con-
sequence of the scaffold volumetric shrinkage upon
sintering. Quantification of microstructural parameters
yielded the following results: pore width 180± 25 μm, pore
height 147± 19 μm, and strut diameter 300± 10 μm. )ese
findings are consistent with those from SEM observations;
the low values of standard deviation confirmed the good
reproducibility of the robocasting process.
A slight curvature in the rods of the scaffold structure is
visible in Figure 4(a). )is could be due to (i) the slight
bending of the ink filaments under their own weight prior to
sintering and (ii) shrinkage phenomena that occur during
sintering.
)ree-dimensional reconstructions of the whole scaffold
volume are also displayed in Figure 5.
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3.2. In Vitro Bioactivity. A biomaterial for bone repair is
dened “bioactive” if HA precipitates onto its surface
once it is implanted inside a living body or during
immersion in solutions that simulate the body envi-
ronment (in vitro) [44]. XRD analyses on the samples
soaked in SBF for dierent time frames actually
300μm
(a)
200μm
(b)
40μm
(c)
Figure 3: Morphological evaluation of the scaold. Top view of the grid-like structure obtained by optical microscopy (a); SEMmicrograph
of the channel porous structure (b) and of the trabecular section (c).
Table 1: Micro-CT scanning parameters.
Scaold Magnication Voxel size(µm)
Rotation
step (°)
Exposure
time (s)
Tube
mode
Frame
averaging
number
Frame skipped
Scaold as-such 10.00x 5.00 0.50 1.5 0 3 1
Scaold soaked for 2 weeks in SBF 11.11x 4.50 0.50 1.5 0 3 1
In
te
ns
ity
 (c
ou
nt
s) 0
50
150
200
250
300
350
400
As-quenched
600°C
30 40 50 60 7020
2θ (°)
Figure 2: XRD patterns. Both the as-quenched 47.5B glass powders (red) and the powdered scaolds sintered at 600°C for 1 h (black) are
characterized by the amorphous structure since no crystallization peaks were observed.
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revealed the formation of HA on the scaffold surface
(Figure 6).
Specifically, there was a progressive disappearance of the
amorphous halo typical of the glass and the appearance of
the HA characteristic diffraction peaks. )e two main peaks
of HA (PDF code no. 01-073-1731) were detected, the
highest at 31.79° (corresponding to the (2 1 1) reflection) and
the other one at 25.68° ((0 0 2) reflection). )ese peaks are
not sharp but have a quite broad appearance, suggesting that
the HA formed on the scaffold struts has a nanocrystalline
nature.
A better understanding of the in vitro bioactivity
mechanism of 47.5B scaffolds was obtained performing
morphological and compositional analyses by SEM and EDS
assisted by micro-CT imaging.)us, it was possible to follow
the stepwise evolution of the scaffold surface, including the
formation of the silica gel, the precipitation of the amor-
phous calcium-phosphate layer, and the nucleation and
growth of HA crystals, according to the bioactivity mech-
anism proposed by Hench [45]. After 6 h, it is possible to see
the formation of the silica gel (the typical surface-cracked
layer in Figure 7(a)), and at 24 h, small calcium-phosphate
nuclei are visible as brighter globules on the surface of the
underlying gel (Figure 7(b)). )is layer evolved leading to
the formation of needle-like HA crystals that grew and
joined together to form large globular crystals with “cauli-
flower morphology,” which is typical of bone-like HA
(Figures 7(c)–7(e)). After 1 week, the scaffold struts are
thicker as compared to those of untreated scaffolds and are
covered by HA globular aggregates. After 2 weeks, no sig-
nificant thickening of the scaffold rods is observed, sug-
gesting that a process of HA detachment from the scaffold
(a) (b)
1mm
(c)
Figure 4: Micro-CT images of 47.5B scaffolds. Vertical section on a plane that passes through the gap between 2 central rods (a); vertical
section on a plane that cuts through the rods parallel to the image plane (b); horizontal section on the midheight of the scaffold, showing also
the border of the scaffold (c) (nominal strut diameter: 300 μm).
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might have taken place. is is evidenced by the fact that the
HA crystals detected on the scaold walls are smaller
compared to the ones that covered the 1-week specimen, as it
is possible to see in Figure 7(d). e Ca-to-P atomic ratio
increases with soaking time from 0.46 at 24 h to 1.47 at
2 weeks. e Ca-to-P ratio at the end of the experiments is
still lower that the value of stoichiometric HA (Ca/P 1.67),
revealing the presence of Ca-decient HA as already ob-
served previously for other bioactive glass compositions
[46–48]. However, as Mg2+ ions are released from the glass
(a)
1mm
(b)
Figure 5: 3D reconstruction of scaold volume obtained by micro-CT. Lateral view (a); top view (b) (nominal strut diameter: 300 μm).
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Figure 6: XRD spectra of 47.5B scaolds after dierent immersion times in SBF. e characteristic peaks of HA are indicated by Miller
indices (h k l).
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100μm 40μm 10μm
(a)
100μm 40μm 10μm
(b)
100μm 40μm 10μm
(c)
100μm 40μm 10μm
(d)
100μm 40μm 10μm
(e)
Figure 7: SEM morphological analysis performed after immersion in SBF at different time points. Typical silica gel layer observed on the
surface of the material after soaking for 6 h (a); small calcium-phosphate nuclei formed after 24 h (b); gel layer evolution upon soaking
observed after 72 h (c); formation of a thick layer of globular HA characterized by the typical cauliflower morphology after 1-week
immersion (d); morphology evaluation of the surface after 2 weeks revealed a partial detachment of the HA with no significant changes in
the rod diameter (e).
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surface during immersion in SBF, a small amount of Ca in
HA has been substituted by Mg, as confirmed by compo-
sitional analysis. )erefore, the atomic ratio between the
amounts of bivalent cations and phosphorus (Ca +Mg)/P
yields 1.64, which is closer to the Ca/P value of stoichio-
metric HA.
)e micro-CT analysis of the scaffold structure after
2weeks in SBF highlighted the presence of different reaction
layers in the rods resulting from the bioactivity mechanism
(Figure 8).
Some rods clearly exhibit a thick silica gel layer (grey
tones) with a thin converted outer layer of HA (white tones).
Other struts, mainly at the scaffold periphery, present a quite
thick HA coating and a core converted to silica gel. A third
type of rods is represented by the trabeculae in the center of
the scaffold which are almost unmodified. HA and bioactive
glass, which have higher densities than silica gel, are
highlighted in Figure 8(b).
Ions are released from the glass surface during the re-
action stages of the bioactivity mechanism; therefore, it is
possible to gain some additional information about this
process by monitoring the evolution of the ionic concen-
tration in SBF during the dissolution test. In fact, it was
previously shown that greater changes in ionic concentra-
tions can be related to higher bioactivity [49].
Silicon concentration increases steadily over the first
week (Figure 9), when the glass converts into silica gel re-
leasing soluble Si(OH)4, and reaches the equilibrium at
1week after the formation of an HA layer. Also, a similar
trend was observed for calcium ions within 1week, but a
plateau was not reached.
)e trend of phosphorus is indicative of the seques-
tration of phosphate ions from the solution, which means
that calcium phosphate—and then HA—precipitates for the
whole soaking period. )is is in good agreement with the
SEM and micro-CT observations (Figures 6 and 8). )e
trends of magnesium and potassium ions are in accordance
with the evolution of the silicon concentration in the first
week, confirming a progressive dissolution of the glass.
However, while silicon concentration reaches a plateau after
1week, the concentrations of magnesium and potassium in
SBF still tend to increase over the whole testing period. )e
evolution of the ionic concentrations of Si, Ca, and P is in
agreement with previous studies on the dissolution of
bioactive silicate glasses [50]. )e release of sodium is not
reported because its concentration, extremely high within
the SBF solution, oversaturated the detector.
)e pH of the solution was also monitored during the
test as its variations are strongly related to the ionic ex-
changes between glass and SBF. )e pH values, shown in
Figure 9, exhibit a rapid increase in the first 24 h, and then
the increase in pH slowed down. )is is consistent with the
morphological observations of the sample: since the pH is
modified by the ionic exchanges between the glass and the
solution, once the HA layer starts to form and limit the glass-
SBF interactions, the ion exchange rate decreases too.
3.3. Mechanical Strength. )e compressive strength of as-
printed scaffolds was in the range of 5.6–16.5MPa
(9.9±4.6MPa), which is comparable to the typical range
assessed for the human cancellous bone (2–12MPa [51]).
Future optimizations in the process of scaffold fabrication could
allow reducing the high variability of the mechanical strength.
)e mechanical properties of scaffolds should ideally
match those of the host bone, and this is challenging es-
pecially in load-bearing applications. )e advent of additive
manufacturing technologies disclosed fascinating scenarios
in this regard. An interesting study carried out by Rainer
et al. [52] established the basis for successfully achieving the
design of scaffolds with the microarchitecture predicted
through a priori finite-element analysis (FEA) of the implant
site geometry under physiological loads. )is approach,
called the load-adaptive scaffold architecturing (LASA), uses
FEA for obtaining the principal stress directions under a
physiologically derived load system and can easily be cou-
pled to CAD-based manufacturing technologies. Although
the applications of LASA are currently limited to polymeric
materials, extension to glasses and ceramics would be highly
beneficial for the field of BTE scaffolds.
When a scaffold is implanted in a load-bearing site, its
major function is to act as a template for the new bone
growth while supporting the surrounding tissues, exactly as
a healthy bone does. )us, the mechanical properties of the
scaffold need to be suitable at the moment of the implan-
tation and, furthermore, should not decrease too fast during
1mm
BG
HA
sg
(a)
1mm
(b)
Figure 8: Cross section of a 47.5B scaffold soaked in SBF for two weeks obtained by micro-CT. (a) Standard condition and (b) augmented
contrast. HA, hydroxyapatite layer; sg, silica gel; BG, unmodified bioactive glass.
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the healing time. e compressive strength of the scaolds
decreases as the immersion time in SBF increases
(5.6± 2.2MPa after 2weeks and 3.3± 0.7MPa after 4 weeks)
but still remains within the typical range of the trabecular
bone (2–12MPa [51]). is trend is in agreement with the
results reported by Motealleh et al. [30] who used robo-
casting to fabricate 45S5 Bioglass® scaolds with a grid-likestructure.
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Figure 9: Ion-release proles related to Si (a), Ca (b), P (c), Mg (d), and K (e) and pH (f) trend upon soaking in SBF. e variation of ionic
concentration in the solution is reported after the subtraction of the ion concentration of blank SBF.
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4. Conclusions
Bioactive glass scaffolds were obtained by a relatively simple
robocasting process that does not require the use of ultrafine
glass powder, very thin nozzles, and a complex experimental
setup, which are usually needed in the processes reported in
the literature. )e process allowed fabricating macroporous
scaffolds with well-reproducible microstructural features,
such as pore size and rod diameter. )e compressive
strength of the scaffolds, which remains comparable to that
of the cancellous bone even after prolonged immersion in
SBF with ionic dissolution phenomena, combined with a
clear apatite-forming capability supports the potential
suitability of the material for bone repair applications.
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